"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about NAPROXEN
• Ask Community about NAPROXEN
• NAPROXEN Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

NAPROXEN Safety Questions, NAPROXEN Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about NAPROXEN. Our extensive database of NAPROXEN adverse events and NAPROXEN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about NAPROXEN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

NAPROXEN Safety Reports

Total NAPROXEN reports: 156.
NAPROXEN FDA safety alerts: 2002 2004 .
Reported deaths: 34    Reported hospitalizations: 91.
Take NAPROXEN Side Effects Survey or Share Your NAPROXEN Story. NAPROXEN Usage.

Showing 1-75 of 156 Next >

Pharmacist from UNITED STATES reported NAPROXEN problem on Aug 03, 2006. Male patient, 58 years of age, weighting 205.0 lb, was diagnosed with pain, procedural pain, coronary artery disease and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: gastric disorder, haematemesis, haematocrit decreased, haemoglobin decreased, post procedural complication. NAPROXEN dosage: unknown. During the same period patient was treated with KETOROLAC, ASPIRIN. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Health Professional from UNITED KINGDOM on July 17, 2006. Male patient was diagnosed with arthritis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: deafness transitory, ototoxicity, tinnitus. NAPROXEN dosage: unknown. During the same period patient was treated with FLURBIPROFEN. Patient recovered.

Consumer or non-health professional from reported NAPROXEN problem on July 24, 2006. Female patient, 29 years of age, was diagnosed with laboratory test and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, asthma, bronchospasm, rhinitis. NAPROXEN dosage: unknown. During the same period patient was treated with METAMIZOL, CODEINE, ACETAMINOPHEN, MELOXICAM. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from on July 24, 2006. Male patient, 47 years of age, was diagnosed with laboratory test and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, asthma. NAPROXEN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, CODEINE, MELOXICAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NAPROXEN problem on Aug 02, 2006. Male patient, 48 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: abdominal wall abscess, intestinal fistula, large intestine perforation. NAPROXEN dosage: 500 MILLIGRAM ORAL. During the same period patient was treated with PRINIVIL. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on Aug 11, 2006. Female patient, 51 years of age, was diagnosed with inflammation, pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: asthenia, blood pressure systolic decreased, dizziness, duodenal ulcer, dyspnoea, gastric ulcer, haematocrit decreased, haemoglobin decreased, heart rate increased. NAPROXEN dosage: unknown. During the same period patient was treated with SULFASALAZINE, PREDNISONE, CEPHALEXIN, COMBIVENT, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Health Professional from DENMARK reported NAPROXEN problem on July 24, 2006. Male patient, 71 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. NAPROXEN dosage: 500 MG;BID;PO. During the same period patient was treated with DIHYDROCODEINE. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from DENMARK on July 31, 2006. Male patient, 70 years of age, was diagnosed with neck pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dizziness, helicobacter gastritis. NAPROXEN dosage: 500 MG; BID; PO. During the same period patient was treated with ADALAT, BENDROFLUAZIDE, OMEPRAZOLE, ACETAMINOPHEN, CODEINE, SENNA, DOCUSATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported NAPROXEN problem on July 31, 2006. Female patient, 80 years of age, was diagnosed with arthralgia and was treated with NAPROXEN. NAPROXEN dosage: 250 MG;BID;PO. During the same period patient was treated with LANSOPRAZOLE, PARACETAMOL, CIPROFLOXACIN. Patient died.

NAPROXEN problem was reported by a Health Professional from UNITED STATES on Aug 22, 2006. Male patient, 49 years of age, weighting 250.0 lb, was diagnosed with pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: cold sweat, dizziness, duodenal ulcer haemorrhage, feeling cold, melaena, rectal haemorrhage. NAPROXEN dosage: 500 MG BID PO. During the same period patient was treated with IBUPROFEN, ASPIRIN, METOPROLOL TARTRATE, NITROGLYCERIN, OMEPRAZOLE, PYRIDOXINE, SIMVASTATIN, FOSINOPRIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported NAPROXEN problem on Aug 08, 2006. Female patient, 71 years of age, was diagnosed with arthritis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: gastric ulcer, haemoglobin decreased, oesophageal ulcer. NAPROXEN dosage: 375 MG; BID; PO. During the same period patient was treated with AMITRIPTYLINE, FUROSEMIDE, MEDROXYPROGESTERONE, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from DENMARK on Aug 08, 2006. Male patient, 19 years of age, was diagnosed with arthralgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: anaemia, duodenal ulcer, gastrointestinal haemorrhage. NAPROXEN dosage: 500 MG; BID; PO. During the same period patient was treated with PARACETAMOL. Patient recovered.

Pharmacist from UNITED STATES reported NAPROXEN problem on Aug 29, 2006. Male patient, 70 years of age, weighting 246.9 lb, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: swelling face, urticaria. NAPROXEN dosage: unknown. During the same period patient was treated with GLIPIZIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from FINLAND on Aug 30, 2006. Male patient, weighting 6.89 lb, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: breech presentation, caesarean section, cleft lip, cleft palate, dysmorphism, hip dysplasia, hypertelorism of orbit, limb hypoplasia congenital. NAPROXEN dosage: 550 MG 2X/WK TP. During the same period patient was treated with BISOPROLOL FUMARATE, SUMATRIPTAN SUCCINATE, PARACETAMOL. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported NAPROXEN problem on Aug 30, 2006. Female patient, 64 years of age, weighting 143.3 lb, was diagnosed with lower respiratory tract infection, osteoporosis prophylaxis, oedema and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: encephalitis, hepatic necrosis, jaundice, liver function test abnormal. NAPROXEN dosage: unknown. During the same period patient was treated with AMOXICILLIN, ADCAL D, BUMETANIDE, ACETAMINOPHEN W, KLIOVANCE. Patient was hospitalized and became disabled. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from DENMARK on Sept 08, 2006. Female patient, 64 years of age, was diagnosed with arthralgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: encephalitis, hepatic necrosis, jaundice, liver transplant. NAPROXEN dosage: 250 MG TID PO. During the same period patient was treated with AMOXICILLIN, ACETAMINOPHEN W, KLIOVANCE, BUMETANIDE, ADCAL. Patient was hospitalized. Patient recovered.

Physician from TURKEY reported NAPROXEN problem on Aug 24, 2006. Male patient, 63 years of age, was diagnosed with cancer pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: bedridden, burning sensation, inadequate analgesia, nausea, pain, sedation, vomiting. NAPROXEN dosage: unknown. During the same period patient was treated with MORPHINE, TRAMADOL, AMITRIPTYLINE, DURAGESIC, BUPIVACAINE, KETAMINE. Patient was hospitalized. Patient died.

NAPROXEN problem was reported by a Physician from TURKEY on Aug 24, 2006. Male patient, 41 years of age, was diagnosed with cancer pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: arthralgia, constipation, discomfort, insomnia, metastases to spine, nausea, pain in extremity, sedation. NAPROXEN dosage: unknown. During the same period patient was treated with MORPHINE, TRAMADOL, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported NAPROXEN problem on Sept 13, 2006. Female patient, weighting 4.19 lb, was diagnosed with myalgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: anuria, blood pressure decreased, caesarean section, candidiasis, disseminated intravascular coagulation, electrolyte imbalance, ileitis. NAPROXEN dosage: unknown. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on Sept 20, 2006. Male patient, 56 years of age, weighting 248.0 lb, was diagnosed with pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. NAPROXEN dosage: 375MG X1 PO. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NAPROXEN problem on Oct 04, 2006. Male patient, 65 years of age, weighting 189.6 lb, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: haemorrhage. NAPROXEN dosage: unknown. During the same period patient was treated with MELOXICAM. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Physician from TURKEY on Oct 03, 2006. Female patient, weighting 4.41 lb, was diagnosed with myalgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: caesarean section, foetal growth retardation, kidney malformation, oligohydramnios, placental disorder, premature baby, renal tubular disorder. NAPROXEN dosage: 1100 MG, DAY. Patient died.

Pharmacist from UNITED STATES reported NAPROXEN problem on Oct 12, 2006. Female patient was diagnosed with arthralgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: haematemesis, upper gastrointestinal haemorrhage. NAPROXEN dosage: 500 MG DAILY PO. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on Oct 12, 2006. Male patient, 61 years of age, weighting 258.8 lb, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. NAPROXEN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from CANADA reported NAPROXEN problem on Sept 28, 2006. Male patient, 48 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: renal failure acute, renal tubular necrosis. NAPROXEN dosage: 375 MG, TID; ORAL. During the same period patient was treated with TENOFOVIR. Patient died.

NAPROXEN problem was reported by a Consumer or non-health professional from NETHERLANDS on Oct 09, 2006. Female patient, 43 years of age, weighting 130.1 lb, was diagnosed with rheumatoid arthritis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea exertional. NAPROXEN dosage: 1000 MG, ORAL. During the same period patient was treated with PLAQUENIL, KEPPRA. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported NAPROXEN problem on Sept 13, 2006. Female patient, weighting 4.19 lb, was diagnosed with myalgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: apgar score low, caesarean section, candida sepsis, dialysis, disseminated intravascular coagulation, foetal growth retardation, foetal movements decreased. NAPROXEN dosage: unknown. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on Oct 31, 2006. Male patient, 58 years of age, weighting 169.8 lb, was diagnosed with arthralgia, back pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, paraesthesia, respiratory distress, throat irritation. NAPROXEN dosage: 250MG BID ORAL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NAPROXEN problem on Oct 31, 2006. Male patient, weighting 308.0 lb, was diagnosed with pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: lower gastrointestinal haemorrhage. NAPROXEN dosage: 375MG TWICE A DAY PO. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2006. Male patient, 40 years of age, was diagnosed with sinusitis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: asthenia, blood pressure increased, headache, heart rate increased, thirst, wheezing. NAPROXEN dosage: 500 MG, ORAL. During the same period patient was treated with AVELOX, SYNTHROID, AZULFIDINE, ZETIA, ZYRTEC, HUMALOG, LISINOPRIL, SINGULAIR. Patient recovered.

Pharmacist from UNITED STATES reported NAPROXEN problem on Nov 08, 2006. Male patient, 85 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: gastric ulcer, upper gastrointestinal haemorrhage. NAPROXEN dosage: unknown. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on Nov 13, 2006. Male patient, 77 years of age, weighting 224.0 lb, was diagnosed with inflammation, pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, hyponatraemia. NAPROXEN dosage: 500MG BID PO. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported NAPROXEN problem on Nov 07, 2006. Female patient, 63 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: alcohol use, intentional overdose. NAPROXEN dosage: unknown. During the same period patient was treated with ETHANOL. Patient died.

NAPROXEN problem was reported by a Health Professional from GERMANY on Nov 06, 2006. Female patient, 79 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: completed suicide, intentional overdose. NAPROXEN dosage: unknown. During the same period patient was treated with VERAPAMIL, GLUCOSAMINE. Patient died.

Consumer or non-health professional from TURKEY reported NAPROXEN problem on Oct 31, 2006. Female patient, 27 years of age, was diagnosed with myalgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: caesarean section, foetal growth retardation, foetal movements decreased, oligohydramnios, premature labour. NAPROXEN dosage: 1100 MG QDAY UNK. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Physician from TURKEY on Oct 31, 2006. Female patient, weighting 4.19 lb, was diagnosed with complication of pregnancy, myalgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: anuria, blood creatinine increased, blood culture positive, blood potassium increased, blood sodium decreased, blood urea increased, caesarean section, disseminated intravascular coagulation in newborn. NAPROXEN dosage: 1100 MG QDAY UNK. Patient was hospitalized. Patient died.

Consumer or non-health professional from reported NAPROXEN problem on Nov 21, 2006. Female patient, 27 years of age, was diagnosed with myalgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: caesarean section, oligohydramnios. NAPROXEN dosage: 1100 MG/DAY. During the same period patient was treated with MEDICINALPRODUCT NOT SPECIFIED BY SENDER. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from on Nov 21, 2006. Female patient, weighting 4.19 lb, was diagnosed with candidiasis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, anuria, caesarean section, candida sepsis, candidiasis, disseminated intravascular coagulation, fungal peritonitis. NAPROXEN dosage: MOTHER TOOK 1100 MG/DAY DURING SECOND TRIMESTER. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.

Physician from UNITED STATES reported NAPROXEN problem on Oct 24, 2006. Female patient, 79 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: completed suicide. NAPROXEN dosage: unknown. During the same period patient was treated with VERAPAMIL, GLUCOSAMINE. Patient died.

NAPROXEN problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 63 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: completed suicide. NAPROXEN dosage: unknown. During the same period patient was treated with ETHANOL. Patient died.

Physician from UNITED STATES reported NAPROXEN problem on Oct 24, 2006. Female patient, 55 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: completed suicide. NAPROXEN dosage: unknown. During the same period patient was treated with ASPIRIN, CARISOPRODOL. Patient died.

NAPROXEN problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 77 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: completed suicide. NAPROXEN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN. Patient died.

Pharmacist from UNITED STATES reported NAPROXEN problem on Nov 27, 2006. Female patient, weighting 213.8 lb, was diagnosed with musculoskeletal pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood potassium increased. NAPROXEN dosage: 220MG TID PO. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2006. Female patient, 60 years of age, weighting 180.0 lb, was diagnosed with inflammation, pain in extremity and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: chest pain, hyperhidrosis, nausea, pulse absent. NAPROXEN dosage: unknown. Patient died on 10/20/2006.

Health Professional from POLAND reported NAPROXEN problem on Nov 13, 2006. Female patient, 30 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, nasal congestion, pulmonary oedema, shock. NAPROXEN dosage: unknown. During the same period patient was treated with IBUPROFEN, CELECOXIB, ASPIRIN. Patient recovered.

NAPROXEN problem was reported by a Physician from POLAND on Nov 14, 2006. Female patient, 30 years of age, was diagnosed with allergy test and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, allergy test positive, flushing, forced expiratory volume decreased, heart rate increased, hypersensitivity, nasal disorder, pulmonary oedema. NAPROXEN dosage: unknown. During the same period patient was treated with IBUPROFEN, ASPIRIN, CELECOXIB. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NAPROXEN problem on Nov 10, 2006. Male patient, 82 years of age, weighting 180.0 lb, was diagnosed with pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: gastric perforation, haemorrhage, kidney perforation, loss of consciousness. NAPROXEN dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from on Nov 28, 2006. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: gastric disorder, gastrointestinal haemorrhage, intestinal diaphragm disease, intestinal obstruction, nausea. NAPROXEN dosage: unknown. During the same period patient was treated with ROFECOXIB. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NAPROXEN problem on Dec 01, 2006. Male patient, 62 years of age, weighting 165.0 lb, was diagnosed with back pain, sciatica, cerebrovascular accident and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: anaemia, angina pectoris, chest pain, duodenal ulcer, duodenitis, gastritis, melaena, oesophagitis, upper gastrointestinal haemorrhage. NAPROXEN dosage: 500 MG BID PO. During the same period patient was treated with ASPIRIN, ATENOLOL, CAPSAICIN CREAM, DOXEPIN, GABAPENTIN, HYDROCODONE BITARTRATE. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Female patient, 83 years of age, weighting 136.9 lb, was diagnosed with osteoarthritis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: dehydration, mycobacterium avium complex infection, renal failure acute. NAPROXEN dosage: 375 MG ORAL TID. Patient recovered.

Pharmacist from UNITED STATES reported NAPROXEN problem on Dec 07, 2006. Male patient, 48 years of age, weighting 164.0 lb, was diagnosed with musculoskeletal pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. NAPROXEN dosage: 250 MG ONE BID PO. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from European Union on Dec 05, 2006. Female patient was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: sepsis, upper gastrointestinal haemorrhage. NAPROXEN dosage: unknown. During the same period patient was treated with ADCAL, FRUSEMIDE, ISOSORBIDE, PERINDOPRIL ERBUMINE, RISPERIDONE, ZOPICLONE. Patient died.

Consumer or non-health professional from NETHERLANDS reported NAPROXEN problem on Dec 12, 2006. Male patient, 26 years of age, was diagnosed with tonsillitis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. NAPROXEN dosage: 1000 MG (500 MG,2 IN 1 D). During the same period patient was treated with PHENETHICILLIN POTASSIUM, AUGMENTIN. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on May 16, 2007. Male patient, 66 years of age, weighting 158.7 lb, was diagnosed with arthralgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood pressure decreased, dizziness, erosive duodenitis, faeces discoloured, gastritis erosive, occult blood positive, pain in extremity. NAPROXEN dosage: 500 MG BID -PT TOOK MORE- PO. During the same period patient was treated with GABAPENTIN, ALLOPURINOL, SERTRALINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported NAPROXEN problem on July 09, 2007. Female patient, 68 years of age, was diagnosed with osteoarthritis, hypertension, urinary tract infection and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, electrocardiogram change, fluid overload, gastrointestinal disorder, hepatic failure, nausea, overdose. NAPROXEN dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, PREDNISONE, METHYLSULFONYLMETHANE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 04, 2007. Male patient, 47 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic, large intestine perforation, peritonitis, sepsis. NAPROXEN dosage: 500 MG; QD; PO. During the same period patient was treated with PREGABALIN, NORTRIPTYLINE, BUPRENORPHINE, TRAMADOL. Patient recovered.

Health Professional from UNITED KINGDOM reported NAPROXEN problem on July 05, 2007. Male patient, 47 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic, large intestine perforation, peritonitis, sepsis. NAPROXEN dosage: unknown. During the same period patient was treated with BUPRENORPHINE, NORTRIPTYLINE, PREGABALIN, TRAMADOL. Patient was hospitalized and became disabled. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from JAPAN on July 09, 2007. Male patient, 70 years of age, was diagnosed with pyrexia, insomnia, convulsion prophylaxis, constipation, neurogenic bladder, sputum retention and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: liver disorder, oculomucocutaneous syndrome, sepsis. NAPROXEN dosage: UNIT DOSE: 100 MG. During the same period patient was treated with ROHYPNOL, CERCINE, AMOBAN, MAGMITT, PHENOBARBITAL, MYSLEE, UBRETID, SPELEAR. Patient died on 10/12/2006.

Pharmacist from JAPAN reported NAPROXEN problem on July 09, 2007. Male patient, 70 years of age, was diagnosed with pyrexia, insomnia, convulsion prophylaxis, constipation, neurogenic bladder, sputum retention and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: liver disorder, oculomucocutaneous syndrome, sepsis. NAPROXEN dosage: UNIT DOSE: 100 MG. During the same period patient was treated with ROHYPNOL, CERCINE, AMOBAN, MAGMITT, PHENOBARBITAL, MYSLEE, UBRETID, SPELEAR. Patient died on 10/12/2006.

NAPROXEN problem was reported by a Physician from JAPAN on July 23, 2007. Male patient, 70 years of age, weighting 132.3 lb, was diagnosed with pyrexia, convulsion prophylaxis, hypertension and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: liver disorder, sepsis, stevens-johnson syndrome. NAPROXEN dosage: unknown. During the same period patient was treated with ROHYPNOL, CERCINE, PERDIPINE, AMOBAN. Patient died on 10/12/2006.

Health Professional from SINGAPORE reported NAPROXEN problem on July 23, 2007. Male patient, 16 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: face oedema, rhonchi. NAPROXEN dosage: unknown. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on July 31, 2007. Male patient, 54 years of age, was diagnosed with pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: alcohol use, duodenal ulcer, haemorrhage. NAPROXEN dosage: 500MG BID PO. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported NAPROXEN problem on July 23, 2007. Female patient, 77 years of age, was diagnosed with atrial fibrillation and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. NAPROXEN dosage: unknown. During the same period patient was treated with WARFARIN. Patient died.

NAPROXEN problem was reported by a Physician from JAPAN on July 23, 2007. Male patient, 70 years of age, weighting 132.3 lb, was diagnosed with pyrexia, convulsion prophylaxis, hypertension and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: liver disorder, sepsis, stevens-johnson syndrome. NAPROXEN dosage: unknown. During the same period patient was treated with ROHYPNOL, CERCINE, PERDIPINE, AMOBAN. Patient died on 10/12/2006.

Consumer or non-health professional from UNITED STATES reported NAPROXEN problem on Aug 03, 2007. Male patient, 14 years of age, weighting 146.0 lb, was diagnosed with pain in extremity and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, hypersensitivity, rash, swelling. NAPROXEN dosage: unknown. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2007. Male patient, 81 years of age, was diagnosed with arthralgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: gastric haemorrhage, renal impairment. NAPROXEN dosage: 375MG BID PO. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NAPROXEN problem on Aug 07, 2007. Male patient, 66 years of age, was diagnosed with osteoarthritis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, haemodialysis, nausea, renal failure acute, vomiting. NAPROXEN dosage: 220 MG DAILY PO. During the same period patient was treated with ACE INHIBITOR, PRESTARIUM, CALCIUM CITRATE, SIMETHICONE, INDAPAMIDE. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from FINLAND on July 30, 2007. Female patient, 82 years of age, was diagnosed with arthralgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: epistaxis. NAPROXEN dosage: 500 MG; BID; PO. During the same period patient was treated with PROPRANOLOL, ESTRADIOL. Patient recovered.

Health Professional from UNITED STATES reported NAPROXEN problem on Aug 08, 2007. Female patient, 79 years of age, weighting 166.0 lb, was diagnosed with osteoarthritis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: renal failure. NAPROXEN dosage: unknown. During the same period patient was treated with NEXIUM, ADALAT, LIPITOR, DIPHENHYDRAMINE HYDROCHLORIDE, TYLENOL, ZESTRIL, DIHYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient died on 08/01/2007.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on Aug 24, 2007. Male patient, 63 years of age, was diagnosed with osteoarthritis and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastric haemorrhage, gastritis, gastrointestinal ulcer. NAPROXEN dosage: 500MG BID PO. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported NAPROXEN problem on Aug 17, 2007. Male patient, child 10 years of age, was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: renal failure acute, renal tubular necrosis. NAPROXEN dosage: unknown. During the same period patient was treated with GENTAMICIN, DICLOFENAC, LAXATIVE NOS. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on Aug 24, 2007. Male patient, 68 years of age, was diagnosed with pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: alcoholism, duodenal ulcer. NAPROXEN dosage: 500MG BID PO. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NAPROXEN problem on Sept 04, 2007. Female patient, 28 years of age, was diagnosed with back pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: overdose, respiratory disorder, swollen tongue. NAPROXEN dosage: unknown. During the same period patient was treated with MOTRIN. Patient was hospitalized. Patient recovered.

NAPROXEN problem was reported by a Pharmacist from UNITED STATES on Sept 07, 2007. Female patient, 52 years of age, was diagnosed with headache and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: dizziness, gastric ulcer, haematocrit decreased, haemoglobin decreased, red blood cell count decreased, upper gastrointestinal haemorrhage. NAPROXEN dosage: 500MG TID PRN HEADACHE PO. During the same period patient was treated with IBUPROFEN, DULOXETINE, DIVALPROEX, LEVOTHYROXINE, AMLODIPINE, LABETALOL, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NAPROXEN problem on Sept 13, 2007. Male patient, 78 years of age, was diagnosed with pain and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. NAPROXEN dosage: 500MG BID PO. Patient was hospitalized. Patient recovered.

Showing 1-75 of 156 Next >

Ask Our Patient Community about NAPROXEN
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate)